U.S. market Open. Closes in 2 hours 48 minutes

AVIR | Atea Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312022-06-302021-12-312021-06-302020-12-312019-12-312018-12-31
RevenueN/AN/A351.37M351.37M48.63M48.63MN/AN/A
Cost of Revenue70.09M260.00KN/A29.00KN/A19.00K17.00KN/A
Gross Profit-70.09M-260.00K351.37M351.34M48.63M48.61M-17.00KN/A
Operating Expenses94.07M130.65M212.99M212.99M59.66M59.66M14.61M9.48M
Selling, General & Admin49.92M48.71M45.78M45.78M21.64M21.64M4.44M2.80M
Research & Development132.84M81.94M167.21M167.21M38.02M38.02M10.17M6.67M
Other Operating Expenses-88.69MN/AN/AN/AN/AN/AN/AN/A
Operating Income-164.16M-130.65M138.38M138.38M-11.03M-11.03M-14.61M-9.48M
Other Expenses / Income29.22M11.15M213.00K213.00K83.00K83.00K574.00K413.00K
Before Tax Income-134.94M-119.50M138.59M138.59M-10.95M-10.95M-14.03M-9.06M
Income Tax Expenses1.02M-3.59M17.40M17.40M-83.00K-83.00K-574.00K413.00K
Net Income-135.96M-115.91M121.19M121.19M-10.86M-10.86M-13.46M-9.06M
Interest ExpensesN/A11.15MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding83.39M83.25M82.82M82.82M21.59M82.44M82.62M47.29M
Diluted Shares Outstanding83.39M83.25M88.25M88.25M21.59M82.44M82.62M47.29M
EBITDA-119.59M-130.65M138.38M138.38M-11.01M-11.01M-14.59M-9.46M
EBITDA Margin0.00%0.00%39.38%39.38%-22.64%-22.64%0.00%0.00%
EBIT-134.94M-108.35M138.59M138.59M-10.95M-10.95M-14.03M-8.65M
EBIT Margin0.00%0.00%39.44%39.44%-22.51%-22.51%0.00%0.00%
Financial Year End2023-12-312022-12-312022-06-302021-12-312021-06-302020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙